Padovano presides over NJ State Court GLP-1 lawsuit The New Jersey Supreme Court has determined that lawsuits filed in NEW JERSEY STATE COURTS related to Ozempic (Wegovy) vision loss, NAION and vision complications will continue to be dealt with separately from the ongoing Ozempic lawsuits related to stomach paralysis and assorted gastrointestinal complications
We selected SURMOUNT-5 because its transparent, peer-reviewed, methodologically rigorous, and mirrors real-world GLP-1 use: weekly injections, common health challenges, modern obesity doses, identical background conditions
Easy for accountability to dissolve in the boom
Its not about discipline
At Eyelid & Facial Plastic Surgery Associates , Dr
With the FDA approval of Novos Wegovy pill on December 22, 2025, we are entering a new era where access to oral GLP-1 medications will continue to grow